{"DataElement":{"publicId":"5206891","version":"1","preferredName":"Hormone Replacement Therapy Pharmaceutical Formulation Type","preferredDefinition":"The form of hormone replacement therapy the participant has used.","longName":"HRMN_REP_TX_FORM_TYP","context":"BBRB","contextVersion":"1","DataElementConcept":{"publicId":"5205056","version":"1","preferredName":"Hormone Replacement Therapy Pharmaceutical Formulation","preferredDefinition":"Treatment with estrogens or estrogen/progesterone after menopause or ovariectomy to prevent pathological effects of decreased estrogen production._The composition of a dosage form, including the characteristics of its raw materials and the operations required to process it.Formulation factors include chemical nature of the drug (ester, salt, complex, etc), drug solubility in water and organic solvents, particle size and surface area, type of dosage form (solution, suspension, capsule, tablet) and the excipients and processes used in the manufacturing of the drug delivery systems. The design of optimal drug delivery systems is thus an important part of providing an effective therapeutic.Official formulations for approved agents are presented in such books as the National Formulary and US Pharmacopeia. Whereas at one time, these were detailed and almost recipe-like, more recent entries may be limited to specifying the formula and imposing a standard limit for the active agent.","longName":"2436239v1.0:5205054v1.0","context":"BBRB","contextVersion":"1","ObjectClass":{"publicId":"2436239","version":"1","preferredName":"Hormone Replacement Therapy","preferredDefinition":"RAEB: Treatment with estrogens or estrogen/progesterone after menopause or ovariectomy to prevent pathological effects of decreased estrogen production.","longName":"C15599","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hormone Replacement Therapy","conceptCode":"C15599","definition":"Treatment with estrogens or estrogen/progesterone after menopause or ovariectomy to prevent pathological effects of decreased estrogen production.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"06F397CB-46AF-08F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-12-12","modifiedBy":"ONEDATA","dateModified":"2005-12-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5205054","version":"1","preferredName":"Pharmaceutical Formulation","preferredDefinition":"The composition of a dosage form, including the characteristics of its raw materials and the operations required to process it.Formulation factors include chemical nature of the drug (ester, salt, complex, etc), drug solubility in water and organic solvents, particle size and surface area, type of dosage form (solution, suspension, capsule, tablet) and the excipients and processes used in the manufacturing of the drug delivery systems. The design of optimal drug delivery systems is thus an important part of providing an effective therapeutic.Official formulations for approved agents are presented in such books as the National Formulary and US Pharmacopeia. Whereas at one time, these were detailed and almost recipe-like, more recent entries may be limited to specifying the formula and imposing a standard limit for the active agent.","longName":"C42638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pharmaceutical Formulation","conceptCode":"C42638","definition":"The composition of a dosage form, including the characteristics of its raw materials and the operations required to process it.Formulation factors include chemical nature of the drug (ester, salt, complex, etc), drug solubility in water and organic solvents, particle size and surface area, type of dosage form (solution, suspension, capsule, tablet) and the excipients and processes used in the manufacturing of the drug delivery systems. The design of optimal drug delivery systems is thus an important part of providing an effective therapeutic.Official formulations for approved agents are presented in such books as the National Formulary and US Pharmacopeia. Whereas at one time, these were detailed and almost recipe-like, more recent entries may be limited to specifying the formula and imposing a standard limit for the active agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EFD7A53-7676-169F-E050-BB89AD432600","latestVersionIndicator":"Yes","beginDate":"2016-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-03-26","modifiedBy":"ONEDATA","dateModified":"2016-03-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435024","version":"1","preferredName":"Drug or Chemical","preferredDefinition":"A category of organic or inorganic substances, elements, and isotopes used in research or for the prevention, diagnosis, and/or treatment of disease states. Includes biologically active substances that are either synthetically manufactured or endogenous substances extracted and processed to be reintroduced into an organism. Chemicals and drugs also include hazardous substances, and naturally occurring or synthetically produced substances required to maintain life.","longName":"C1908","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07431EBC-FB04-25D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"BPV: Biospecimen Pre-analytical Variables (BPV) Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EFD7A53-7687-169F-E050-BB89AD432600","latestVersionIndicator":"Yes","beginDate":"2016-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-03-26","modifiedBy":"HARTLEYG","dateModified":"2016-07-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5205057","version":"1","preferredName":"Hormone Therapy Pharmaceutical Formulation Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"5205057v1.0","context":"BBRB","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"25","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other - specify","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2EFD7A53-76B6-169F-E050-BB89AD432600","beginDate":"2016-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-03-26","modifiedBy":"ONEDATA","dateModified":"2016-03-26","deletedIndicator":"No"},{"value":"UnknownÂ ","valueDescription":"Unknown","ValueMeaning":{"publicId":"2565695","version":"1","preferredName":"Unknown","longName":"2565695","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CDAC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-02-26","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-02-26","modifiedBy":"MMADDINENI","dateModified":"2024-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2EFD7A53-76C0-169F-E050-BB89AD432600","beginDate":"2016-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-03-26","modifiedBy":"ONEDATA","dateModified":"2016-03-26","deletedIndicator":"No"},{"value":"Cream","valueDescription":"Spermicidal Cream","ValueMeaning":{"publicId":"5205058","version":"1","preferredName":"Spermicidal Cream","longName":"5205058","preferredDefinition":"A vaginal cream that is deleterious to sperm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Spermicidal Cream","conceptCode":"C92883","definition":"A vaginal cream that is deleterious to sperm.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EFD7A53-76CD-169F-E050-BB89AD432600","latestVersionIndicator":"Yes","beginDate":"2016-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-03-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2EFD7A53-76E6-169F-E050-BB89AD432600","beginDate":"2016-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-03-26","modifiedBy":"ONEDATA","dateModified":"2016-03-26","deletedIndicator":"No"},{"value":"Patch","valueDescription":"Contraceptive Patch","ValueMeaning":{"publicId":"3263711","version":"1","preferredName":"Contraceptive Patch","longName":"3263711","preferredDefinition":"A dermal patch that contains estrogen and progestin hormones for release and absorption through the skin and into the body to prevent pregnancy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Contraceptive Patch","conceptCode":"C92760","definition":"A dermal patch that contains estrogen and progestin hormones for release and absorption through the skin and into the body to prevent pregnancy.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB4A30D3-88F6-04A6-E040-BB89AD4310B8","latestVersionIndicator":"Yes","beginDate":"2011-08-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-08-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2EFD7A53-76FA-169F-E050-BB89AD432600","beginDate":"2016-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-03-26","modifiedBy":"ONEDATA","dateModified":"2016-03-26","deletedIndicator":"No"},{"value":"Pill","valueDescription":"Pill Dosage Form","ValueMeaning":{"publicId":"2579108","version":"1","preferredName":"Pill Dosage Form","longName":"2579108","preferredDefinition":"A dose of medicine in the form of a small pellet.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pill Dosage Form","conceptCode":"C25394","definition":"A solid composed of a small, round object composed of active and/or inert ingredient(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0211-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-04","modifiedBy":"KUMMEROA","dateModified":"2022-12-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2EFD7A53-770F-169F-E050-BB89AD432600","beginDate":"2016-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-03-26","modifiedBy":"ONEDATA","dateModified":"2016-03-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435024","version":"1","preferredName":"Drug or Chemical","preferredDefinition":"A category of organic or inorganic substances, elements, and isotopes used in research or for the prevention, diagnosis, and/or treatment of disease states. Includes biologically active substances that are either synthetically manufactured or endogenous substances extracted and processed to be reintroduced into an organism. Chemicals and drugs also include hazardous substances, and naturally occurring or synthetically produced substances required to maintain life.","longName":"C1908","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07431EBC-FB04-25D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"BPV: Biospecimen Pre-analytical Variables (BPV) Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EFD7A53-769F-169F-E050-BB89AD432600","latestVersionIndicator":"Yes","beginDate":"2016-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-03-26","modifiedBy":"HARTLEYG","dateModified":"2016-07-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5188870","version":"1","longName":"BPV - Tumor Biospecimen Acquisition","context":"BBRB","ClassificationSchemeItems":[{"publicId":"5405791","version":"1","longName":"BPV - Tumor Biospecimen Acquisition","context":"BBRB"},{"publicId":"6736428","version":"1","longName":"Ovary Clinical Data Entry","context":"BBRB"}]}],"AlternateNames":[{"name":"BBRB","type":"USED_BY","context":"BBRB"}],"ReferenceDocuments":[{"name":"Form of hormone replacement t","type":"Preferred Question Text","description":"Form of hormone replacement therapy","url":null,"context":"BBRB"}],"origin":"BPV: Biospecimen Pre-analytical Variables (BPV) Program","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2F36E331-B9C7-DEFD-E050-BB89AD43555B","latestVersionIndicator":"Yes","beginDate":"2016-03-29","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-03-29","modifiedBy":"HARTLEYG","dateModified":"2019-04-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}